(1) Agencia Española de Medicamentos y Productos Ssanitarios. Adasuve (LOXAPINA). En: Informe mensual sobre Medicamentos de Uso Humano y Productos...
(2) Citrome L. Inhaled loxapine for agitation. Current Psychiatry 2013; 12(2): 31-6 [Accesible en: http://www.currentpsychiatry.com/article_pages.asp?aid=11056].
(3) Luz verde en la UE a la comercialización de loxapina. Jano.es, 26 de febrero de 2013 [Accesible en: http://www.jano. es/jano/actualidad/ultimas/noticias/janoes/...
(4) Bainbridge E, Gallagher A, McDonald G, McDonald C, Ahmed M. General practitioners’ attitudes on who should manage metabolic dysregulations...
(5) Jin H, Shih PA, Golshan S, Mu- daliar S, Henry R, Glorioso DK, et al. Comparison of longer-term safety and effectiveness of 4 atypical...
(6) Moran M. Risk-Benefit Ratio Not Favorable for Use of Atypicals in Older Adults. Psychiatric News 2012; 47 (24): 19-19 [Accesible en: http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=1487344]
(7) Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, et al. Relapse risk after discontinuation of risperidone in...
(8) Arehart-Treichel J. Stopping Antipsychotics Raises Relapse Risk in AD. Psychiatric News 2012; Volume 47 (23): 25-25 [Accesible en: http://psychnews.psychiatryonline.org/newsArticle....
(9) Comunicación Dirigida a Pro- fesionales Sanitarios sobre el riesgo de hepatotoxicidad con agomelatina ( Valdoxan/ Thymanax) [Accesible...
(10) Kosinski EC, Rothschild AJ. Monoamine oxidase inhibitors: Forgotten treatment for depression. Current Psychiatry 2012; 11(12): 21-26...
(11) Centro de Información online de Medicamentos de la AEMPS – CIMA. Información sobre Parnate [Accesible en: http:// www.aemps.gob.es/cima/especialidad.do?me...
(12) Castro VM, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, et al. QT interval and antidepressant use: a cross sectional study...
(13) Washington NB, Brahm NC, Kissack J. Which psychotropics carry the greatest risk of QTc prolongation? Current Psychiatry 2012; 11(10):...
(14) Scarff JR. Options for treating antidepressant-induced sweating. Current Psychiatry 2013; 12(1): 51 [Accesible en: http://www.currentpsychiatry.com/article_pages.asp?AID=11007].
(15) Sansone RA, Sansone LA. SSRIs: bad to the bone? Innov Clin Neurosci 2012; 9: 42-7 [Accesible en: http://www.ncbi. nlm.nih.gov/pmc/articles/PMC3442753/pdf/...
(16) Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B. Neurodevelopment of children following prenatal exposure to venlafaxine,...
(17) Sinclair L. Caution Urged Before Stopping Antidepressants in Pregnancy. Psuchiatric News 2012; 47 (12): 24-29 [Accesible en: http://psychnews.psychiatryonline.org/...
(18) Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, et al. Selective Serotonin Reuptake Inhibitors During Pregnancy and...
(19) imenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Lander AR, Afzal S, et al. SSRI Use During Pregnancy and Risk of Stillbirth and...
(20) Friedman SH, Hall, RCW. Antidepressant use during pregnancy: How to avoid clinical and legal pitfalls. Current Psychiatry 2013; 12(2):...
(21) Food and Drug Administration. Strattera (atomoxetine hydrochloride) capsule [Accesible en: http://www.fda.gov/Safety/ MedWatch/SafetyInformation/ucm223889....
(22) Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, et al. Cardiovascular safety of central nervous system stimulants...
(23) Poulton AS, Melzer E, Tait PR, Garnett SP, Cowell CT, Baur LA et al. Growth and pubertal development of adolescent boys on stimulant...
(24) Food and Drug Administration. Lamictal (lamotrigine) Tablets, Chewable Dispersible Tablets, Lamictal Orally Disinte- grating Tablets,...
(25) Food and Drug Administration. Topamax (topiramate) tablets and sprinkle capsules. [Accesible en: http://www.fda. gov/Safety/MedWatch/SafetyInformation/...
(26) Wiseman CN, y Gören JL. Can topiramate reduce nightmares in posttraumatic stress disorder. Current Psychiatry 2013; 12 (3): E1-E2. [Accesible...
(27) Kung S, Espinel Z, Lapid MI. Treatment of nightmares with prazosin: a systematic review. Mayo Clin Proc 2012; 87: 890-900 [Accesible...
(28) Medicines and Healthcare products Regulatory Agency. Carbamazepine, oxcarbazepine and eslicarbazepine: potential risk of serious skin...
(29) Sirven JI, Noe K, Hoerth M, Drazkowski J. Antiepileptic Drugs 2012: Recent Advances and Trends. Mayo Clin Proc 2012; 87: 879-89 [Accesible...
(30) Europa Press. Uno de cada tres españoles ha tomado un ansiolítico en el último año, 8 de febrero de 2013 [Accesible en: http:// www.europapress.es/salud/noticia-cada-tresespanoles-utilizado-algun-medicamento-ansiedad-ultimo-ano-20130208121455.html]
(31) Agencia Española del Medicamento y Productos Sanitarios. Inicio de la revisión de la seguridad de los medicamentos que contienen tetrazepam,...
(32) Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues JF, Pérès K, et al. Benzodiazepine use and risk of dementia: prospective...
(33) Kripke DF, Langer RD, Kline LE. Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ Open 2012; 2(1):e000850....
(34) Kao CH, Sun LM, Liang JA, Chang SN, Sung FC, Muo CH. Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study....
(35) Phillips BA. Insomnia, hypnotic drug use, and patient well-being: first, do no harm. Mayo Clin Proc 2012; 87: 417-8 [Accesible en: http://download.journals.elsevierhealth.com/pdfs/journals/0025-6196/...
(36) Huang HY, Hsu YT, Wu YC, Chiou SM, Kao CH, Tsai MC, et al. Zolpidem improves neuropsychiatric symptoms and motor dysfunction in a patient...
(37) Food and Durg Administration. Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses, Including...
(38) Instituto Nacional de Toxicología y Ciencias Forenses. Memoria 2011 [Accesible en: https://www.administraciondejusticia.gob.es/paj/PA_WebApp_SGNTJ_...
(39) Chang CM, Wu EC, Chen CY, Wu KY, Liang HY, Chau YL, et al. Psychotropic Drugs and Risk of Motor Vehicle Accidents: a Population-based...
(40) Kuehn BM. FDA warning: Driving may be impaired the morning following sleeping pill use. JAMA 2013; 309: 645-6 [Accesible en: http://jama.jamanetwork.com/...
(41) Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of...
(42) Kollen BJ, van der Veen WJ, Groenhof F, Donker GA, van der Meer K. Discontinuation of reimbursement of benzodiazepines in the Netherlands:...
(43) Dormuth CR, Miller TA, Huang A, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network. Effect of a centralized...
(44) Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, et al. Effects of moderate-dose treatment with varenicline on...
(45) Food and Drug Administration. FDA Drug Safety Communication: Safety review update of Chantix (varenicline) and risk of cardiovascular...
(46) Dent R, Blackmore A, Peterson J, Habib R, Kay GP, Gervais A, Taylor V, Wells G. Changes in body weight and psychotropic drugs: a systematic...
(47) Fankhauser MP, Ellingrod MS. Drug interactions with tobacco smoke: Implications for patient care. Current Psychiatry 2013; 12(1): 12-6...
(48) Irwig MS. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects. J Clin Psychiatry...
(49) Medicines and Healthcare pro- ducts Regulatory Agency. Drug Safety Alert: Roflumilast (Daxas): risk of suicidal behaviour – avoid use...
(50) Drazen JM.Transparency for clinical trials--the TEST Act. N Engl J Med 2012; 367: 863-4 [Accesible en: http://www. nejm.org/doi/pdf/10.1056/NEJMe1209433]
(52) Siegel-Itzkovich J. Viagra makes flowers stand right. BMJ 1999; 319: 274 [Accesible en: http://bmj.bmjjournals.com/cgi/ reprint/319/7205/274/a?maxtoshow=&HITS...
(53) Benotti MJ, Trenholm MJ, Vanderford BJ, Holady JC, Stanford BD et al. Pharmaceuticals and Endocrine Disrupting Compounds in U.S. Drinking...
(54) Fent K, Weston AA, Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006; 76: 122-159 [Abstract en: http://www.ncbi.nlm.nih.gov/pubmed/16257063].
(55) Gaworecki KM, Klaine SJ. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquat Toxicol...
(56) De Lange HJ, Noordoven W, Murk AJ, Lürling M, Peeters ET. Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations...
(57) Fong PP. Zebra mussel spawning is induced in low concentrations of putative serotonin reuptake inhibitors. Biol Bull 1998; 194: 143-149...
(58) Guler Y, Ford AT. Anti-depressants make amphipods see the light Aquatic Toxicology 2010, 99: 397-404 [Abstract en: http://www.ncbi.nlm.nih.gov/...